Assembly of human severe acute respiratory syndrome coronavirus-like particles
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Viral particles of human severe acute respiratory syndrome coronavirus (SARS CoV) consist of three virion structural proteins, including spike protein, membrane protein, and envelope protein. In this report, virus-like particles were assembled in insect cells by the co-infection with recombinant baculoviruses, which separately express one of these three virion proteins. We found that the membrane and envelope proteins are sufficient for the efficient formation of virus-like particles and could be visualized by electron microscopy. Sucrose gradient purification followed by Western blot analysis and immunogold labeling showed that the spike protein could be incorporated into the virus like particle also. The construction of engineered virus-like particles bearing resemblance to the authentic one is an important step towards the development of an effective vaccine against infection of SARS CoV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Cited by
Coronavirus envelope protein: current knowledge
Schoeman, D., & Fielding, B. C. (2019) · Virology Journal · doi:10.1186/s12985-019-1182-0 · Cited by 2,074
Baculovirus as versatile vectors for protein expression in insect and mammalian cells
Kost, T. A., Condreay, J. P., & Jarvis, D. L. (2005) · Nature Biotechnology · doi:10.1038/nbt1095 · Cited by 1,014
Kushnir, N., Streatfield, S. J., & Yusibov, V. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.083 · Cited by 587
Siu, Y. L., Teoh, K. T., Lo, J., Chan, C. M., Kien, F., Escriou, N., Tsao, S. W., Nicholls, J. M., Altmeyer, R., Peiris, J. S. M., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01052-08 · Cited by 501
Neuman, B. W., Adair, B. D., Yoshioka, C., Quispe, J. D., Orca, G., Kuhn, P., Milligan, R. A., Yeager, M., & Buchmeier, M. J. (2006) · Journal of Virology · doi:10.1128/jvi.00645-06 · Cited by 438
DeDiego, M. L., Álvarez, E., Almazán, F., Rejas, M. T., Lamirande, E., Roberts, A., Shieh, W.-J., Zaki, S. R., Subbarao, K., & Enjuanes, L. (2007) · Journal of Virology · doi:10.1128/jvi.01467-06 · Cited by 438
Production of virus-like particles for vaccines
Fuenmayor, J., Gòdia, F., & Cervera, L. (2017) · New Biotechnology · doi:10.1016/j.nbt.2017.07.010 · Cited by 318
SARS coronavirus E protein forms cation-selective ion channels
Wilson, L., Mckinlay, C., Gage, P., & Ewart, G. (2004) · Virology · doi:10.1016/j.virol.2004.09.033 · Cited by 293
Yasui, F., Kai, C., Kitabatake, M., Inoue, S., Yoneda, M., Yokochi, S., Kase, R., Sekiguchi, S., Morita, K., Hishima, T., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6337 · Cited by 252
Mortola, E., & Roy, P. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.09.009 · Cited by 250
Tregoning, J. S., Brown, E. S., Cheeseman, H. M., Flight, K. E., Higham, S. L., Lemm, N.-M., Pierce, B. F., Stirling, D. C., Wang, Z., & Pollock, K. M. (2020) · Clinical and Experimental Immunology · doi:10.1111/cei.13517 · Cited by 224
Coronavirus virulence genes with main focus on SARS-CoV envelope gene
DeDiego, M. L., Nieto-Torres, J. L., Jimenez-Guardeño, J. M., Regla-Nava, J. A., Castaño-Rodriguez, C., Fernandez-Delgado, R., Usera, F., & Enjuanes, L. (2014) · Virus Research · doi:10.1016/j.virusres.2014.07.024 · Cited by 177
“In fact, E protein seems necessary for virus like paricle formation using some experimental systems (Ho et al., 2004; ortola and Roy, 2004) but not others (Huang et al., 2004).”
Virus‑like particles as a vaccine delivery system: Myths and facts
Roy, P., & Noad, R. (2008) · Human Vaccines · doi:10.4161/hv.4.1.5559 · Cited by 163
Animal tissue culture principles and applications
Verma, A., Verma, M., & Singh, A. (2020) · Animal Biotechnology · doi:10.1016/b978-0-12-811710-1.00012-4 · Cited by 161
Current advancements and potential strategies in the development of MERS-CoV vaccines
Zhang, N., Jiang, S., & Du, L. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.912134 · Cited by 158
“It is worth noting that the minimal components essential for VLP formation and the immunogenicity induced by VLPs need to be considered.”
BackgroundInfluentialBai, B., Hu, Q., Hu, H., Zhou, P., Shi, Z., Meng, J., Lu, B., Huang, Y., Mao, P., & Wang, H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002685 · Cited by 59
Metadata
- Authors
- Ho, Y., Lin, P.-H., Liu, C. Y. Y., Lee, S.-P., & Chao, Y.-C.
- Venue
- Biochemical and Biophysical Research Communications
- Publisher
- Elsevier BV
- Published
- 2004-06
- Volume
- 318
- Issue
- 4
- Pages
- 833-838
- ISSN
- 0006-291X (ISSN-L)
- OpenAlex
- W2015065935
- Cited by
- 114
- References
- 1
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.